{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:06:42Z","timestamp":1789556802983,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,2]],"date-time":"2019-01-02T00:00:00Z","timestamp":1546387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2019,1,2]],"date-time":"2019-01-02T00:00:00Z","timestamp":1546387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-018-1213-y","type":"journal-article","created":{"date-parts":[[2019,1,2]],"date-time":"2019-01-02T10:30:36Z","timestamp":1546425036000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["RETRACTED ARTICLE: Agranulocytosis-Protective Olanzapine-Loaded Nanostructured Lipid Carriers Engineered for CNS Delivery: Optimization and Hematological Toxicity Studies"],"prefix":"10.1208","volume":"20","author":[{"given":"Dnyandev G.","family":"Gadhave","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amol A.","family":"Tagalpallewar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandrakant R.","family":"Kokare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,2]]},"reference":[{"key":"1213_CR1","doi-asserted-by":"publisher","first-page":"4169","DOI":"10.1016\/j.actbio.2011.07.025","volume":"7","author":"U Seju","year":"2011","unstructured":"Seju U, Kumar A, Sawant KK. Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery: in vitro and in vivo studies. Acta Biomater. 2011;7:4169\u201376.","journal-title":"Acta Biomater"},{"key":"1213_CR2","first-page":"473","volume":"117","author":"CM Dela","year":"2017","unstructured":"Dela CM, Danoff R. Thrombocytopenia and spontaneous intracranial hemorrhage after olanzapine therapy. J Am Osteopath Assoc. 2017;117:473\u2013175.","journal-title":"J Am Osteopath Assoc"},{"key":"1213_CR3","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/PRA.0000000000000292","volume":"24","author":"W LS-C","year":"2018","unstructured":"LS-C W, Tee CK, Gan LLY. Olanzapine-induced and risperidone-induced leukopenia: a case of synergistic adverse reaction? J Psychiatr Pract. 2018;24:121\u20134.","journal-title":"J Psychiatr Pract"},{"key":"1213_CR4","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1080\/10611860802476504","volume":"16","author":"M Kumar","year":"2008","unstructured":"Kumar M, Misra A, Ak M, Mishra P, Pathak K. Mucoadhesive nanoemulsion-based intranasal drug delivery system of olanzapine for brain targeting. J Drug Target. 2008;16:806\u201314.","journal-title":"J Drug Target"},{"key":"1213_CR5","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S0278-5846(01)00258-5","volume":"26","author":"C Tolosa-Vilella","year":"2002","unstructured":"Tolosa-Vilella C, Ruiz-Ripoll A, Mari-Alfonso B, Naval-Sendra E. Olanzapine-induced agranulocytosis: a case report and review of the literature. Prog Neuropsychopharmacol Biol Psychiatry. 2002;26:411\u20134.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1213_CR6","first-page":"S13","volume":"58","author":"CM Beasley","year":"1997","unstructured":"Beasley CM, Tollefson GD, Tran PV. Safety of olanzapine. J Clin Psychiatry. 1997;58:S13\u20137.","journal-title":"J Clin Psychiatry"},{"key":"1213_CR7","first-page":"5871","volume":"7","author":"K Malhotra","year":"2015","unstructured":"Malhotra K, Vu P, Wang DH, Lai H, Faziola LR. Olanzapine-induced neutropenia. Ment Illn. 2015;7:5871.","journal-title":"Ment Illn"},{"key":"1213_CR8","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.ijpharm.2009.06.019","volume":"379","author":"A Mistry","year":"2009","unstructured":"Mistry A, Stolnik S, Illum L. Nanoparticles for direct nose-to-brain delivery of drugs. Int J Pharm. 2009;379:146\u201357.","journal-title":"Int J Pharm"},{"key":"1213_CR9","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/00004714-200004000-00032","volume":"20","author":"LK Oyewumi","year":"2000","unstructured":"Oyewumi LK, Al-Semaan Y. Olanzapine: safe during clozapine induced agranulocytosis. J Clin Psychopharmacol. 2000;20:279\u201381.","journal-title":"J Clin Psychopharmacol"},{"key":"1213_CR10","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1517\/17425247.2013.790887","volume":"10","author":"CV Pardeshi","year":"2013","unstructured":"Pardeshi CV, Belgamwar VS. Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood-brain barrier: an excellent platform for brain targeting. Expert Opin Drug Deliv. 2013;10:957\u201372.","journal-title":"Expert Opin Drug Deliv"},{"key":"1213_CR11","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jconrel.2014.06.053","volume":"189","author":"L Kozlovskaya","year":"2014","unstructured":"Kozlovskaya L, Kaoud MA, Stepensky D. Quantitative analysis of drug delivery to the brain via nasal route. J Control Release. 2014;189:133\u201340.","journal-title":"J Control Release"},{"key":"1213_CR12","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.addr.2011.12.005","volume":"64","author":"WA Banks","year":"2012","unstructured":"Banks WA. Drug delivery to the brain in Alzheimer\u2019s disease: consideration of the blood-brain barrier. Adv Drug Deliv Rev. 2012;64:629\u201339.","journal-title":"Adv Drug Deliv Rev"},{"key":"1213_CR13","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ijpharm.2014.08.064","volume":"47","author":"KM Hosny","year":"2014","unstructured":"Hosny KM, Hassan AH. Intranasal in situ gel loaded with squinavir mesylate nanosized microemulsion: preparation, characterization, and in vivo evaluation. Int J Pharm. 2014;47:191\u20137.","journal-title":"Int J Pharm"},{"key":"1213_CR14","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.jconrel.2012.01.024","volume":"161","author":"L Illum","year":"2012","unstructured":"Illum L. Nasal drug delivery\u2014recent developments and future prospects. J Control Release. 2012;161:254\u201363.","journal-title":"J Control Release"},{"key":"1213_CR15","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ijbiomac.2013.06.041","volume":"61","author":"M Kumar","year":"2013","unstructured":"Kumar M, Pandey RS, Patra KC, Jain SK, Soni ML, Dangi JS, et al. Evaluation of neuropeptide loaded trimethyl chitosan nanoparticles for nose to brain delivery. Int J Biol Macromol. 2013;61:189\u201395.","journal-title":"Int J Biol Macromol"},{"key":"1213_CR16","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.ejpb.2008.10.009","volume":"72","author":"S Horvat","year":"2009","unstructured":"Horvat S, Feher A, Wolburg H, Sipos P, Veszelka S, Toth A, et al. Sodium hyaluronate as a mucoadhesive component in nasal formulation enhances delivery of molecules to brain tissue. Eur J Pharm Biopharm. 2009;72:252\u20139.","journal-title":"Eur J Pharm Biopharm"},{"key":"1213_CR17","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.apsb.2014.02.002","volume":"4","author":"R Pathak","year":"2014","unstructured":"Pathak R, Dash RP, Misra M, Nivsarkar M. Role of mucoadhesive polymers in enhancing delivery of nimodipine microemulsion to brain via intranasal route. Acta Pharm Sin B. 2014;4:151\u201360.","journal-title":"Acta Pharm Sin B"},{"key":"1213_CR18","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.drudis.2015.10.016","volume":"21","author":"C Karavasili","year":"2016","unstructured":"Karavasili C, Fatouros DG. Smart materials: in situ gel-forming systems for nasal delivery. Drug Discov Today. 2016;21:157\u201366.","journal-title":"Drug Discov Today"},{"key":"1213_CR19","doi-asserted-by":"publisher","first-page":"119","DOI":"10.2174\/157341311794480282","volume":"7","author":"RL Shinde","year":"2011","unstructured":"Shinde RL, Jindal AB, Devarajan PV. Microemulsions and nanoemulsions for targeted drug delivery to the brain. Curr Nanosci. 2011;7:119\u201333.","journal-title":"Curr Nanosci"},{"key":"1213_CR20","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ijpharm.2013.02.014","volume":"446","author":"PA Patel","year":"2013","unstructured":"Patel PA, Patil SC, Kalaria DR, Kalia YN, Patravale VB. Comparative in vitro and in vivo evaluation of lipid based nanocarriers of Huperzine A. Int J Pharm. 2013;446:16\u201323.","journal-title":"Int J Pharm"},{"key":"1213_CR21","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3109\/10717544.2013.822945","volume":"20","author":"MI Alam","year":"2013","unstructured":"Alam MI, Baboota S, Ahuja A, Ali M, Ali J, Sahni JK. Intranasal infusion of nanostructured lipid carriers (NLC) containing CNS acting drug and estimation in brain and blood. Drug Deliv. 2013;20:247\u201351.","journal-title":"Drug Deliv"},{"key":"1213_CR22","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1517\/17425247.2014.945416","volume":"12","author":"T Alam","year":"2014","unstructured":"Alam T, Pandit J, Vohora D, Aqil M, Ali A, Sultana Y. Optimization of nanostructured lipid carriers of lamotrigine for brain delivery: in vitro characterization and in vivo efficacy in epilepsy. Expert Opin Drug Deliv. 2014;12:181\u201394.","journal-title":"Expert Opin Drug Deliv"},{"key":"1213_CR23","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.ijpharm.2011.12.009","volume":"423","author":"MJ Tsai","year":"2012","unstructured":"Tsai MJ, Wu PC, Huang YB, Chang JS, Lin CL, Tsai YH, et al. Baicalein loaded in tocol nanostructured lipid carriers (tocol NLCs) for enhanced stability and brain targeting. Int J Pharm. 2012;423:461\u201370.","journal-title":"Int J Pharm"},{"key":"1213_CR24","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.colsurfb.2014.06.037","volume":"122","author":"TB Devkar","year":"2014","unstructured":"Devkar TB, Tekade AR, Khandelwal KR. Surface engineered nanostructured lipid carriers for efficient nose to brain delivery of ondansetron HCl using Delonix regia gum as a natural mucoadhesive polymer. Colloids Surf B Biointerfaces. 2014;122:143\u201350.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"1213_CR25","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.ejpb.2015.08.008","volume":"96","author":"RL Shinde","year":"2015","unstructured":"Shinde RL, Bharkad GP, Devarajan PV. Intranasal microemulsion for targeted nose to brain delivery in neurocysticercosis: role of docosahexaenoic acid. Eur J Pharm Biopharm. 2015;96:363\u201379.","journal-title":"Eur J Pharm Biopharm"},{"key":"1213_CR26","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ijpharm.2015.07.013","volume":"492","author":"M Ferreira","year":"2015","unstructured":"Ferreira M, Chaves LL, Lima SA, Reis S. Optimization of nanostructured lipid carriers loaded with methotrexate: a tool for inflammatory and cancer therapy. Int J Pharm. 2015;492:65\u201372.","journal-title":"Int J Pharm"},{"key":"1213_CR27","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.ijpharm.2009.12.050","volume":"388","author":"R Gannu","year":"2010","unstructured":"Gannu R, Palem CR, Yamsani VV, Yamsani SK, Yamsani MR. Enhanced bioavailability of lacidipine via microemulsion based transdermal gels: formulation optimization, ex vivo and in vivo characterization. Int J Pharm. 2010;388:231\u201341.","journal-title":"Int J Pharm"},{"key":"1213_CR28","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ijpharm.2006.09.060","volume":"332","author":"AS Zidan","year":"2007","unstructured":"Zidan AS, Sammour OA, Hammad MA, Megrab NA, Habib MJ, Khan MA. Quality by design: understanding the formulation variables of a cyclosporine A self-nanoemulsified drug delivery systems by Box\u2013Behnken design and desirability function. Int J Pharm. 2007;332:55\u201363.","journal-title":"Int J Pharm"},{"key":"1213_CR29","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.foodchem.2015.12.061","volume":"199","author":"R Ravanfar","year":"2016","unstructured":"Ravanfar R, Tamaddon AM, Niakousari M, Moein MR. Preservation of anthocyanins in solid lipid nanoparticles: optimization of a microemulsion dilution method using the Placket-Burman and Box-Behnken designs. Food Chem. 2016;199:573\u201380.","journal-title":"Food Chem"},{"key":"1213_CR30","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ejps.2012.10.029","volume":"48","author":"S Pund","year":"2013","unstructured":"Pund S, Rasve G, Borade G. Ex vivo permeation characteristics of venlafaxine through sheep nasal mucosa. Eur J Pharm Sci. 2013;48:195\u2013201.","journal-title":"Eur J Pharm Sci"},{"key":"1213_CR31","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ijpharm.2015.04.015","volume":"487","author":"S Pund","year":"2015","unstructured":"Pund S, Pawar S, Gangurde S, Divate D. Transcutaneous delivery of leflunomide nanoemulgel: mechanistic investigation into physicomechanical characteristics, in vitro anti-psoriatic and anti-melanoma activity. Int J Pharm. 2015;487:148\u201356.","journal-title":"Int J Pharm"},{"key":"1213_CR32","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.ijbiomac.2014.03.022","volume":"67","author":"MS Bhavna","year":"2014","unstructured":"Bhavna MS, Ali M, Ali R, Bhatnagar A, Baboota S, Ali J. Donepezil nanosuspension intended for nose to brain targeting: in vitro and in vivo safety evaluation. Int J Biol Macromol. 2014;67:418\u201325.","journal-title":"Int J Biol Macromol"},{"key":"1213_CR33","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.biopha.2017.07.067","volume":"94","author":"V Pokharkar","year":"2017","unstructured":"Pokharkar V, Patil-Gadhe A, Palla P. Efavirenz loaded nanostructured lipid carrier engineered for brain targeting through intranasal route: in-vivo pharmacokinetic and toxicity study. Biomed Pharmacother. 2017;94:150\u201364.","journal-title":"Biomed Pharmacother"},{"key":"1213_CR34","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/j.fct.2010.05.008","volume":"48","author":"P Dandekar","year":"2010","unstructured":"Dandekar P, Dhumal R, Jain R, Tiwari D, Vanage G, Patravale V. Toxicological evaluation of pH-sensitive nanoparticles of curcumin: acute, sub-acute and genotoxicity studies. Food Chem Toxicol. 2010;48:2073\u201389.","journal-title":"Food Chem Toxicol"},{"key":"1213_CR35","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.ijpharm.2014.04.015","volume":"468","author":"S Qian","year":"2014","unstructured":"Qian S, Wong YC, Zuo Z. Development, characterization and application of in situ gel system for intranasal delivery of tacrine. Int J Pharm. 2014;468:272\u201382.","journal-title":"Int J Pharm"},{"key":"1213_CR36","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1080\/10717544.2016.1233593","volume":"24","author":"RL Shinde","year":"2017","unstructured":"Shinde RL, Devarajan PV. Docosahexaenoic acid-mediated, targeted and sustained brain delivery of curcumin microemulsion. Drug Deliv. 2017;24:152\u201361.","journal-title":"Drug Deliv"},{"key":"1213_CR37","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1208\/s12249-017-0811-4","volume":"19","author":"UA Shinde","year":"2017","unstructured":"Shinde UA, Modani SH, Singh KH. Design and development of repaglinide microemulsion gel for transdermal delivery. AAPS PharmSciTech. 2017;19:315\u201325.","journal-title":"AAPS PharmSciTech"},{"key":"1213_CR38","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.biopha.2017.05.008","volume":"92","author":"V Tzankova","year":"2017","unstructured":"Tzankova V, Aluani D, Kondeva-Burdina M, Yordanov Y, Odzhakov F, Apostolov A, et al. Hepatoprotective and antioxidant activity of quercetin loaded chitosan\/alginate particles in vitro and in vivo in a model of paracetamol-induced toxicity. Biomed Pharmacother. 2017;92:569\u201379.","journal-title":"Biomed Pharmacother"},{"key":"1213_CR39","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.ejps.2012.12.007","volume":"48","author":"S Md","year":"2013","unstructured":"Md S, Khan RA, Mustafa G, Chuttani K, Baboota S, Sahni JK, et al. Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: pharmacodynamic, pharmacokinetic and scintigraphy study in mice model. Eur J Pharm Sci. 2013;48:393\u2013405.","journal-title":"Eur J Pharm Sci"}],"updated-by":[{"DOI":"10.1208\/s12249-026-03543-y","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000}}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-018-1213-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-018-1213-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-018-1213-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T10:47:19Z","timestamp":1789555639000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-018-1213-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,2]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1]]}},"alternative-id":["1213"],"URL":"https:\/\/doi.org\/10.1208\/s12249-018-1213-y","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,2]]},"assertion":[{"value":"6 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been retracted. Please see the Retraction Notice for more detail:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1208\/s12249-026-03543-y","URL":"https:\/\/doi.org\/10.1208\/s12249-026-03543-y","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"All animals required for this study were approved by the institutional animal ethics committee of Sinhgad Institute of Pharmacy, Pune, India, regulated by the CPCSEA (Protocol No. SIOP\/IAEC\/2017\/02\/13).","order":2,"name":"Ethics","label":"Animal Studies","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}}],"article-number":"22"}}